{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:40:43Z","timestamp":1792176043219,"version":"4.4.0"},"reference-count":150,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"School of Pharmacy, The University of Nottingham"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is the most common form of dementia, affecting more than 50 million people worldwide with an estimated increase to 139 million people by 2050. The exact pathogenic mechanisms of AD remain elusive, resulting in the fact that the current therapeutics solely focus on symptomatic management instead of preventative or curative strategies. The two most widely accepted pathogenic mechanisms of AD include the amyloid and tau hypotheses. However, it is evident that these hypotheses cannot fully explain neuronal degeneration shown in AD. Substantial evidence is growing for the vital role of neuroinflammation in AD pathology. The neuroinflammatory hypothesis provides a new, exciting lead in uncovering the underlying mechanisms contributing to AD. This review aims to highlight new insights into the role of neuroinflammation in the pathogenesis of AD, mainly including the involvement of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB), nucleotide-binding oligomerization domain, leucine-rich repeat-containing protein 3 (NLRP3)\/caspase-1 axis, triggering receptor expressed on myeloid cells 2 (TREM2) and cGAS-STING as key influencers in augmenting AD development. The inflammasomes related to the pathways of NF-\u03baB, NLRP3, TREM2, and cGAS-STING as biomarkers of the neuroinflammation associated with AD, as well as an overview of novel AD treatments based on these biomarkers as potential drug targets reported in the literature or under clinical trials, are explored.<\/jats:p>","DOI":"10.3390\/cells11121925","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T23:50:14Z","timestamp":1655250614000},"page":"1925","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer\u2019s Disease and Its Potential for Therapeutic Intervention"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6237-1291","authenticated-orcid":false,"given":"Tiantian","family":"Li","sequence":"first","affiliation":[{"name":"School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8956-8924","authenticated-orcid":false,"given":"Li","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Pember","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinuo","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, China Pharmaceutical University, Nanjing 211112, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bocheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-3812","authenticated-orcid":false,"given":"Zheying","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"ref_1","unstructured":"World Heath Organisation (2022, January 24). Dementia. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer\u2019s Disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ana.23816","article-title":"Brain injury biomarkers are not dependent on \u03b2-amyloid in normal elderly","volume":"73","author":"Knopman","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e154889","DOI":"10.1172\/JCI154889","article-title":"Aducanumab for Alzheimer disease: The amyloid hypothesis moves from bench to bedside","volume":"131","author":"Musiek","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2015.00191","article-title":"Soluble amyloid-\u03b2 oligomers as synaptotoxins leading to cognitive impairment in Alzheimer\u2019s disease","volume":"9","author":"Ferreira","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimer\u2019s Dementia."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-170672","article-title":"Memantine for the Treatment of Dementia: A Review on its Current and Future Applications","volume":"62","author":"Folch","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141959","article-title":"A phase II trial of tideglusib in Alzheimer\u2019s disease","volume":"45","author":"Lovestone","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_13","first-page":"205","article-title":"Treatment of Alzheimer\u2019s disease with the GSK-3 inhibitor tideglusib: A pilot study","volume":"33","author":"Steinwachs","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_14","first-page":"1003","article-title":"Neuroinflammation Induces Neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J. Neurol. Neurosurg Spine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and Biomarker Changes in Dominantly Inherited Alzheimer\u2019s Disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-020-0145-7","article-title":"NLRP3 inflammasome as a novel therapeutic target for Alzheimer\u2019s disease","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s41467-022-29552-6","article-title":"Microglial NF-\u03baB drives tau spreading and toxicity in a mouse model of tauopathy","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS\u2013STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.phrs.2017.11.030","article-title":"Phytochemicals as inhibitors of NF-\u03baB for treatment of Alzheimer\u2019s disease","volume":"129","author":"Seo","year":"2018","journal-title":"Pharmacol Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular Mechanisms That Influence the Macrophage M1\u2013M2 Polarization Balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jep.2016.03.038","article-title":"Chotosan improves A\u03b21-42-induced cognitive impairment and neuroinflammatory and apoptotic responses through the inhibition of TLR-4\/NF-\u03baB signaling in mice","volume":"191","author":"Chen","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fncel.2018.00329","article-title":"Role of Microglia TLRs in Neurodegeneration","volume":"12","author":"Fiebich","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ni1255","article-title":"Essential function for the kinase TAK1 in innate and adaptive immune responses","volume":"6","author":"Sato","year":"2005","journal-title":"Nat. Immunol"},{"key":"ref_29","first-page":"a000158","article-title":"The IKK complex, a central regulator of NF-kappaB activation","volume":"2","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: Mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1189\/jlb.2RI1115-531R","article-title":"TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target","volume":"100","author":"Ullah","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.3389\/fimmu.2020.565924","article-title":"Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro","volume":"11","author":"Gritsenko","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fphar.2021.643254","article-title":"Neurodegenerative Disease and the NLRP3 Inflammasome","volume":"12","author":"Holbrook","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and Regulation of NLRP3 Inflammasome Activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s Disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1038\/emm.2013.147","article-title":"Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"46","author":"Choi","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","article-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation","volume":"33","author":"Li","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2174\/1871527313666140806144831","article-title":"Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress","volume":"13","author":"Cuevas","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-\u03b2 peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-\u03b2 peptide neurotoxicity in Alzheimer\u2019s disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-2009-0976","article-title":"Inflammation and NF-kappaB in Alzheimer\u2019s disease and diabetes","volume":"16","author":"Granic","year":"2009","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-11-25","article-title":"Modulation of inflammation in transgenic models of Alzheimer\u2019s disease","volume":"11","author":"Birch","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology","volume":"85","author":"Doty","year":"2015","journal-title":"Neuron"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neurobiolaging.2014.07.041","article-title":"Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP\/PS1 mice","volume":"36","author":"Yanagisawa","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Hackler, L., \u00d3zsv\u00e1ri, B., Gyuris, M., Sipos, P., F\u00e1bi\u00e1n, G., Moln\u00e1r, E., Marton, A., Farag\u00f3, N., Mih\u00e1ly, J., and Nagy, L.I. (2016). The Curcumin Analog C-150, Influencing NF-\u03baB, UPR and Akt\/Notch Pathways Has Potent Anticancer Activity In Vitro and In Vivo. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149832"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Libro, R., Giacoppo, S., Soundara Rajan, T., Bramanti, P., and Mazzon, E. (2016). Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview. Molecules, 21.","DOI":"10.3390\/molecules21040518"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8791832","DOI":"10.1155\/2017\/8791832","article-title":"Resveratrol Attenuates Microglial Activation via SIRT1-SOCS1 Pathway","volume":"2017","author":"Zhang","year":"2017","journal-title":"Evid. Based Complementary Altern. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1471-4159.2011.07594.x","article-title":"Resveratrol mitigates lipopolysaccharide- and A\u03b2-mediated microglial inflammation by inhibiting the TLR4\/NF-\u03baB\/STAT signaling cascade","volume":"120","author":"Capiralla","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.intimp.2014.12.035","article-title":"IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells","volume":"24","author":"Cianciulli","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-4-21","article-title":"A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer\u2019s disease mouse model","volume":"4","author":"Munoz","year":"2007","journal-title":"J. Neuroinflammation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"R689","DOI":"10.1016\/j.cub.2020.04.065","article-title":"Inflammasomes","volume":"30","author":"Fitzgerald","year":"2020","journal-title":"Curr. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: Mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-5-7","article-title":"The role of interleukin-1 in neuroinflammation and Alzheimer disease: An evolving perspective","volume":"5","author":"Shaftel","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tins.2005.06.008","article-title":"IL-18: A key player in neuroinflammation and neurodegeneration?","volume":"28","author":"Schmidt","year":"2005","journal-title":"Trends Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: Host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0966-842X(00)01937-5","article-title":"Salmonella-induced cell death: Apoptosis, necrosis or programmed cell death?","volume":"9","author":"Boise","year":"2001","journal-title":"Trends Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: Mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"36617","DOI":"10.1074\/jbc.M112.407130","article-title":"Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation","volume":"287","author":"Juliana","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.3389\/fimmu.2021.701282","article-title":"Activation of NLRP3 Inflammasome and Onset of Alzheimer\u2019s Disease","volume":"12","author":"Bai","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Gustin, A., Kirchmeyer, M., Koncina, E., Felten, P., Losciuto, S., Heurtaux, T., Tardivel, A., Heuschling, P., and Dostert, C. (2015). NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130624"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1007\/s12035-019-1638-7","article-title":"The Role of Neuronal NLRP1 Inflammasome in Alzheimer\u2019s Disease: Bringing Neurons into the Neuroinflammation Game","volume":"56","author":"Yap","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/glia.22499","article-title":"Human astrocytes express a novel NLRP2 inflammasome","volume":"61","author":"Minkiewicz","year":"2013","journal-title":"Glia"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e101064","DOI":"10.15252\/embj.2018101064","article-title":"Systemic inflammation impairs microglial A\u03b2 clearance through NLRP3 inflammasome","volume":"38","author":"Tejera","year":"2019","journal-title":"EMBO J."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Krabbe, G., Halle, A., Matyash, V., Rinnenthal, J.L., Eom, G.D., Bernhardt, U., Miller, K.R., Prokop, S., Kettenmann, H., and Heppner, F.L. (2013). Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060921"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16210","article-title":"The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer\u2019s disease (review of Technology Appraisal No. 111): A systematic review and economic model","volume":"16","author":"Bond","year":"2012","journal-title":"Health Technol. Assess."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Kim, J., Lee, H.-J., Park, S.K., Park, J.-H., Jeong, H.-R., Lee, S., Lee, H., Seol, E., and Hoe, H.-S. (2021). Donepezil Regulates LPS and A\u03b2-Stimulated Neuroinflammation through MAPK\/NLRP3 Inflammasome\/STAT3 Signaling. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910637"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","article-title":"Aggregated Tau activates NLRP3\u2013ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo","volume":"137","author":"Stancu","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"32145","DOI":"10.1073\/pnas.2009680117","article-title":"The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"117","author":"Lonnemann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Wang, S., Yang, H., Yu, L., Jin, J., Qian, L., Zhao, H., Xu, Y., and Zhu, X. (2014). Oridonin attenuates A\u03b21-42-induced neuroinflammation and inhibits NF-\u03baB pathway. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104745"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12504","DOI":"10.1038\/ncomms12504","article-title":"Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models","volume":"7","author":"Daniels","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1756286420935676","DOI":"10.1177\/1756286420935676","article-title":"Diclofenac reduces the risk of Alzheimer\u2019s disease: A pilot analysis of NSAIDs in two US veteran populations","volume":"13","author":"Stuve","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jmb.2017.10.004","article-title":"COPs and POPs Patrol Inflammasome Activation","volume":"430","author":"Indramohan","year":"2018","journal-title":"J. Mol. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.immuni.2015.07.018","article-title":"The PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory Disease","volume":"43","author":"Khare","year":"2015","journal-title":"Immunity"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.2829","article-title":"The PYRIN domain\u2013only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA viruses","volume":"15","author":"Khare","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"15556","DOI":"10.1038\/ncomms15556","article-title":"The PYRIN domain-only protein POP2 inhibits inflammasome priming and activation","volume":"8","author":"Ratsimandresy","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Devi, S., Stehlik, C., and Dorfleutner, A. (2020). An Update on CARD Only Proteins (COPs) and PYD Only Proteins (POPs) as Inflammasome Regulators. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186901"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1038\/s41467-020-19227-5","article-title":"Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease","volume":"11","author":"McQuade","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1111\/bph.14618","article-title":"Microglial inflammation and phagocytosis in Alzheimer\u2019s disease: Potential therapeutic targets","volume":"176","author":"Nizami","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","article-title":"Insights into TREM2 biology by network analysis of human brain gene expression data","volume":"34","author":"Forabosco","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e2100356118","DOI":"10.1073\/pnas.2100356118","article-title":"Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice","volume":"118","author":"Schoch","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e2017742118","DOI":"10.1073\/pnas.2017742118","article-title":"Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer\u2019s disease","volume":"118","author":"Ellwanger","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.brainresbull.2020.10.006","article-title":"Mechanism of TREM2\/DAP12 complex affecting \u03b2-amyloid plaque deposition in Alzheimer\u2019s disease modeled mice through mediating inflammatory response","volume":"166","author":"Cui","year":"2021","journal-title":"Brain Res. Bull."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.171.2.594","article-title":"Pattern recognition by TREM-2: Binding of anionic ligands","volume":"171","author":"Daws","year":"2003","journal-title":"J. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 Binds to Apolipoproteins, Including APOE and CLU\/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","article-title":"Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: A longitudinal observational study","volume":"21","author":"Li","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"99456","DOI":"10.15252\/embj.201899456","article-title":"Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments","volume":"37","author":"Lichtenthaler","year":"2018","journal-title":"EMBO J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers","volume":"8","author":"Kleinberger","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","article-title":"Elucidating the Role of TREM2 in Alzheimer\u2019s Disease","volume":"94","author":"Ulrich","year":"2017","journal-title":"Neuron"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/jamaneurol.2015.0979","article-title":"R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study","volume":"72","author":"Korvatska","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13195-020-00709-z","article-title":"TREM2 Alzheimer\u2019s variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages","volume":"12","author":"Agarwal","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 Is a Receptor for \u03b2-Amyloid that Mediates Microglial Function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e20210542","DOI":"10.1084\/jem.20210542","article-title":"Activated microglia mitigate A\u03b2-associated tau seeding and spreading","volume":"218","author":"Gratuze","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1172\/JCI138179","article-title":"Impact of TREM2R47H variant on tau pathology\u2013induced gliosis and neurodegeneration","volume":"130","author":"Gratuze","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","article-title":"TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy","volume":"12","author":"Bemiller","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","article-title":"Cutting edge: TREM-2 attenuates macrophage activation","volume":"177","author":"Turnbull","year":"2006","journal-title":"J. Immunol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s11064-019-02748-x","article-title":"Imbalance of Microglial TLR4\/TREM2 in LPS-Treated APP\/PS1 Transgenic Mice: A Potential Link Between Alzheimer\u2019s Disease and Systemic Inflammation","volume":"44","author":"Zhou","year":"2019","journal-title":"Neurochem. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1093\/hmg\/ddaa209","article-title":"Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions","volume":"29","author":"Liu","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"20862","DOI":"10.18632\/aging.104104","article-title":"TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K\/AKT\/FoxO3a signaling pathway in Alzheimer\u2019s disease mice","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12974-020-01853-x","article-title":"TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K\/Akt pathway after intracerebral hemorrhage in mice","volume":"17","author":"Chen","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"13316","DOI":"10.1038\/s41598-021-91207-1","article-title":"Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome","volume":"11","author":"Cosker","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1189\/jlb.3HI0814-371RR","article-title":"Syk is involved in NLRP3 inflammasome-mediated caspase-1 activation through adaptor ASC phosphorylation and enhanced oligomerization","volume":"97","author":"Lin","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14728222.2018.1486823","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2): A potential therapeutic target for Alzheimer disease?","volume":"22","author":"Deming","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41467-019-09118-9","article-title":"Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model","volume":"10","author":"Zhong","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20160844","article-title":"Soluble TREM2 induces inflammatory responses and enhances microglial survival","volume":"214","author":"Zhong","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","article-title":"Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology","volume":"14","author":"Kleinberger","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.15252\/emmm.201707672","article-title":"An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function","volume":"9","author":"Schlepckow","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e11227","DOI":"10.15252\/emmm.201911227","article-title":"Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region","volume":"12","author":"Schlepckow","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-01915-0","article-title":"Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition","volume":"17","author":"Price","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e20200785","DOI":"10.1084\/jem.20200785","article-title":"Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model","volume":"217","author":"Wang","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e054669","DOI":"10.1002\/alz.054669","article-title":"A phase 1 study of AL002 in healthy volunteers","volume":"17","author":"Ward","year":"2021","journal-title":"Alzheimer\u2019s Dementia"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/WNR.0b013e32835fb6b0","article-title":"Regulation of TREM2 expression by an NF-\u03baB-sensitive miRNA-34a","volume":"24","author":"Zhao","year":"2013","journal-title":"Neuroreport"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1471-4159.2009.06130.x","article-title":"The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor","volume":"110","author":"Stefano","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","article-title":"TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer\u2019s Disease","volume":"103","author":"Griciuc","year":"2019","journal-title":"Neuron"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1152\/jn.00848.2018","article-title":"Neuroinflammation and the cGAS-STING pathway","volume":"121","author":"Chin","year":"2019","journal-title":"J. Neurophysiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/icb.2012.9","article-title":"The interferons and their receptors--distribution and regulation","volume":"90","author":"Nguyen","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.neuron.2017.11.032","article-title":"Activation of the STING-Dependent Type I Interferon Response Reduces Microglial Reactivity and Neuroinflammation","volume":"96","author":"Mathur","year":"2017","journal-title":"Neuron"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Hui, C.W., Zhang, Y., and Herrup, K. (2016). Non-Neuronal Cells Are Required to Mediate the Effects of Neuroinflammation: Results from a Neuron-Enriched Culture System. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147134"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","article-title":"Autophagy induction via STING trafficking is a primordial function of the cGAS pathway","volume":"567","author":"Gui","year":"2019","journal-title":"Nature"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1155\/2013\/102735","article-title":"Role of the Crosstalk between Autophagy and Apoptosis in Cancer","volume":"2013","author":"Su","year":"2013","journal-title":"J. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.molcel.2016.08.025","article-title":"TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune Responses","volume":"64","author":"Chen","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2013.09.049","article-title":"Cyclic Dinucleotides Trigger ULK1 (ATG1) Phosphorylation of STING to Prevent Sustained Innate Immune Signaling","volume":"155","author":"Konno","year":"2013","journal-title":"Cell"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.3389\/fimmu.2020.624597","article-title":"The Trinity of cGAS, TLR9, and ALRs Guardians of the Cellular Galaxy Against Host-Derived Self-DNA","volume":"11","author":"Kumar","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000477092","article-title":"Deletion of the Inflammasome Sensor Aim2 Mitigates A\u03b2 Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model","volume":"24","author":"Wu","year":"2017","journal-title":"Neuroimmunomodulation"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/glia.23592","article-title":"Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression","volume":"67","author":"Nazmi","year":"2019","journal-title":"Glia"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12974-019-1639-5","article-title":"Type I interferon (IFN)-inducible Absent in Melanoma 2 proteins in neuroinflammation: Implications for Alzheimer\u2019s disease","volume":"16","author":"Choubey","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature23890","article-title":"cGAS senses long and HMGB\/TFAM-bound U-turn DNA by forming protein\u2013DNA ladders","volume":"549","author":"Andreeva","year":"2017","journal-title":"Nature"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/glia.22786","article-title":"DNA sensors are expressed in astrocytes and microglia in vitro and are upregulated during gliosis in neurodegenerative disease","volume":"63","author":"Cox","year":"2015","journal-title":"Glia"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbi.2019.07.004","article-title":"Efficacy and mechanism of cGAMP to suppress Alzheimer\u2019s disease by elevating TREM2","volume":"81","author":"Xu","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Wang, W., Hu, D., Wu, C., Feng, Y., Li, A., Liu, W., Wang, Y., Chen, K., Tian, M., and Xiao, F. (2020). STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008335"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1038\/s41467-021-26851-2","article-title":"Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fnins.2021.621501","article-title":"The Complexity of the cGAS-STING Pathway in CNS Pathologies","volume":"15","author":"Fryer","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e2011226118","DOI":"10.1073\/pnas.2011226118","article-title":"NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer\u2019s disease via cGAS-STING","volume":"118","author":"Hou","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/12\/1925\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:31:28Z","timestamp":1760139088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/12\/1925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":150,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["cells11121925"],"URL":"https:\/\/doi.org\/10.3390\/cells11121925","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]}}}